A new treatment for colon cancer that combines a chemotherapy agent approved to treat breast cancer and a cancer-fighting antibody is ready for clinical trials, according to Penn State College of Medicine researchers.
Jun 8, 2011
1
0
Cholesterol tends to get a bad rap through its association with cardiovascular disease. But its role in the body is much more nuanced.
Aug 24, 2022
0
36
Over 17,000 patients will have been diagnosed with locally-advanced pancreatic cancer in the United States in 2011. Surgery is not a treatment option for these patients whose tumor has grown beyond the pancreas to surrounding ...
Dec 14, 2011
0
0
Muscle stem cells, the cells in muscle fibers that generate new muscle cells after injury or exercise, lose their potency with age. But a study by researchers at Stanford Medicine shows that old mice regain the leg muscle ...
Nov 17, 2022
0
48
For around 40 years, scientists all over the world have been unsuccessfully trying to find a cure for HIV, but now a team of researchers from Aarhus University and Aarhus University Hospital have apparently found an important ...
Oct 17, 2022
0
52
New research has found that the weakened immune systems of blood cancer patients can improve after they receive a third COVID-19 vaccination.
Mar 25, 2022
0
98
As COVID-19 continues to evolve and mutate quickly, so do treatment options. While the best ways to prevent the spread of COVID-19 are vaccinations and booster vaccinations, several authorized treatments and preventive drugs, ...
Jan 17, 2022
1
12
Scientists at The Scripps Research Institute (TSRI) have performed successful tests of an experimental methamphetamine vaccine on rats. Vaccinated animals that received the drug were largely protected from typical signs of ...
Nov 1, 2012
1
0
Respiratory syncytial virus (RSV) is a very common virus, typically causing infection in children during the colder months. In most cases, RSV causes a mild illness, with symptoms similar to that of a regular cold.
Nov 21, 2022
0
26
Younger patients with diffuse large B-cell lymphoma given a more intensive regimen of chemotherapy combined with rituximab survive significantly longer, and are approximately twice as likely to remain in remission 3 years ...
Nov 24, 2011
0
0
